Form 13-F position report

SAREPTA THERAPEUTICS INC COM S

Reported by Avidity Partners Management LP

SRPT CUSIP 803607100 Manager CIK 0001791827

Reported 1,055,000 shares, up 106,800 (11.3%) from the prior quarter.

Reported value 30.4%; share count 11.3% vs. the prior quarter.

Added
% of reported 13F value 2.96% This manager · Q4 2022
Shares 1,055,000 Quarter-end amount reported
Reported value $136,706,900 Fair value at quarter end
Consecutive quarters held 2 Through Q4 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2022-09-30 104814000
2022-12-31 136706900
2023-03-31 57337280
2023-06-30 34069700
2023-09-30 54549000
2023-12-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

6 quarters
Quarterly reported position history for SAREPTA THERAPEUTICS INC COM S held by Avidity Partners Management LP.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q4 2023 Reduced 0 -450,000 (-100.0%) 0 $0 2024-02-14
Q3 2023 Added 450,000 +152,500 (51.3%) 2.2% $54,549,000 2023-11-14
Q2 2023 Reduced 297,500 -118,500 (-28.5%) 1.19% $34,069,700 2023-08-14
Q1 2023 Reduced 416,000 -639,000 (-60.6%) 1.9% $57,337,280 2023-05-15
Q4 2022 Added 1,055,000 +106,800 (11.3%) 2.96% $136,706,900 2023-02-14
Q3 2022 New 948,200 +948,200 (0.0%) 2.13% $104,814,000 2022-11-14
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

450 managers reported SAREPTA THERAPEUTICS INC COM S for Q4 2022.

Managers reporting SAREPTA THERAPEUTICS INC COM S in Q4 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Reduced 8,033,264 -52,253 0.03% $1,040,950,349 39 qtrs
JANUS HENDERSON GROUP PLC Reduced 6,028,016 -337,503 0.56% $781,073,641 19 qtrs
BlackRock Inc Added 5,482,166 +144,862 0.02% $710,379,070 39 qtrs
Avoro Capital Advisors LLC Unchanged 3,175,000 0 6.15% $411,416,500 19 qtrs
EcoR1 Capital LLC Unchanged 2,999,453 0 11.83% $388,669,120 4 qtrs
FMR LLC Added 2,716,071 +166,243 0.03% $351,948,496 39 qtrs
WELLINGTON MANAGEMENT GROUP LLP Reduced 2,554,064 -4,805 0.07% $330,955,614 20 qtrs
SANDS CAPITAL MANAGEMENT LLC Reduced 2,151,378 -330,997 1.05% $278,776,000 18 qtrs
THE BANK OF NEW YORK MELLON CORPORATION Added 1,993,833 +110,835 0.06% $258,360,881 39 qtrs
STATE STREET CORPORATION Added 1,941,744 +6,761 0.01% $251,611,188 39 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2022
Filed
February 14, 2023
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
1,055,000
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.